News
Introduction
During autoimmune diseases, such as multiple sclerosis (MS), the body incorrectly recognizes and attacks “self ” tissues. Conventional clinical therapies for MS employ broad immunosuppression, which has provided important benefits for…
We are well into the new academic year and—for those of us in the Northern hemisphere—packing up all our memories from hopefully a wonderful summer.
Teaching is on my mind at this time, in particular an awareness of the increasing numbers of distance education programs and institutions offering…
Mauro Ferrari is the executive vice president of Houston Methodist Hospital (a U.S. News and World Report Honor Roll Hospital, 2016) and the president/CEO of the
Mauro Ferrari in front of the Houston Methodist Research Institute he inaugurated in 2011.Houston Methodist Research Institute, where he…
Introduction
Overexpression of cyclooxegenase-2 (COX-2) is a hallmark of inflammation and an early event in carcinogenesis and cancer progression.1,2 Because COX-2 is expressed in virtually all solid tumors, it represents an ideal biomarker with broad impact for the early clinical detection of…
On April 21 and 22, 2016, Monash Institute of Pharmaceutical Sciences (MIPS) in Melbourne hosted the 2016 Joint Annual Australian–New Zealand CRS Student Workshop
Zach Houston finishes his presentation in front of the magnificent Sissons Mural at Monash Parkville campus.under the theme “Crossing…
Vinod LabhasetwarAt the DDTR editorial board meeting held during the CRS annual meeting in Seattle, I updated several parameters related to the journal and presented my vision for further growth. The most significant news was a 130% increase in citations compared with the year ending July 2015.…
